About this FactMed analysis covering adverse side effect reports of SOMALGIN patients who developed AKINESIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking SOMALGIN reported AKINESIA to the FDA. A total of 285 SOMALGIN drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between SOMALGIN and AKINESIA. In doing so, we compare SOMALGIN with other drugs that cause AKINESIA, to help you evaluate whether or not SOMALGIN causes AKINESIA. Likewise, this page shows the most highly-reported side effects of SOMALGIN, so you can see if AKINESIA ranks among SOMALGIN's most well-known side effects.
Summary Statistics
Reports of SOMALGIN causing AKINESIA: 1
Reports of any side effect of SOMALGIN : 285
Percentage of SOMALGIN patients where AKINESIA is a reported side effect: 0.3509%

FDA reports of any drug causing AKINESIA : 753
Average percentage for all medicated patients where AKINESIA is reported as a complication: 0.0047%

Physician opinion on SOMALGIN as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing SOMALGIN:
ANTICOAGULANT THERAPY ( 28 patients )
CARDIAC DISORDER ( 16 patients )
ANTIPLATELET THERAPY ( 9 patients )
COAGULOPATHY ( 6 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 6 patients )
CARDIOVASCULAR DISORDER ( 4 patients )
PROPHYLAXIS ( 4 patients )
BLOOD DISORDER ( 4 patients )
CARDIAC REHABILITATION THERAPY ( 4 patients )
THROMBOSIS ( 4 patients )
ANALGESIC THERAPY ( 3 patients )
VENOUS OCCLUSION ( 3 patients )
HYPERTENSION ( 3 patients )
PAIN ( 3 patients )
PERIPHERAL VASCULAR DISORDER ( 3 patients )
CEREBROVASCULAR ACCIDENT ( 2 patients )
THROMBOSIS PROPHYLAXIS ( 2 patients )
DIABETES MELLITUS ( 2 patients )
EFFUSION ( 2 patients )
PLATELET AGGREGATION INHIBITION ( 2 patients )
CIRCULATING ANTICOAGULANT ( 2 patients )
CORONARY ARTERY DISEASE ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
ARTERIAL REPAIR ( 2 patients )
PLATELET DISORDER ( 1 patients )
ANGINA PECTORIS ( 1 patients )
ARTERIAL DISORDER ( 1 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 1 patients )
PARKINSON'S DISEASE ( 1 patients )
CAROTID ARTERIOSCLEROSIS ( 1 patients )
ANGIOPLASTY ( 1 patients )
BLOOD PRESSURE MANAGEMENT ( 1 patients )
CARDIAC OPERATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with AKINESIA:

MODOPAR (292 patients)
EFFEXOR (145 patients)
XANAX (129 patients)
VIOXX (116 patients)
STALEVO 100 (111 patients)
ASPIRIN (73 patients)
PERGOLIDE MESYLATE (56 patients)
SINEMET (55 patients)
RISPERDAL (54 patients)
ATHYMIL (52 patients)
COMTAN (45 patients)
MADOPAR (41 patients)
LORAZEPAM (40 patients)
MADOPAR DISPERSIBLE (39 patients)
IMOVANE (38 patients)
ZYPREXA (37 patients)
ATARAX (37 patients)
VALPROATE SODIUM (36 patients)
CLOZAPINE (31 patients)
DEPAKOTE (30 patients)
CITALOPRAM HYDROBROMIDE (29 patients)
CLOBAZAM (29 patients)
FUROSEMIDE (28 patients)
REQUIP (28 patients)
PARLODEL (27 patients)
EXELON (27 patients)
PAXIL (26 patients)
DIGOXIN (25 patients)
LASIX (25 patients)
ERYTHROMYCIN (25 patients)
SEROQUEL (25 patients)
LAMOTRIGINE (25 patients)
RISPERIDONE (24 patients)
GENTAMICIN (24 patients)
PHENYTOIN (23 patients)
AMANTADINE HCL (23 patients)
ACETAMINOPHEN (21 patients)
HALDOL (21 patients)
DIAZEPAM (20 patients)
VALTREX (20 patients)
OMEPRAZOLE (19 patients)
PAROXETINE HCL (19 patients)
ACETAMINOPHEN AND TRAMADOL HCL (18 patients)
CEFOTAXIME (18 patients)
SPIRONOLACTONE (18 patients)
LEVOTHYROXINE SODIUM (18 patients)
TEGRETOL (17 patients)
PREDNISOLONE (17 patients)
DEPAKENE (17 patients)
HALOPERIDOL (17 patients)
SIMVASTATIN (16 patients)
NITROGLYCERIN (16 patients)
ZOLOFT (15 patients)
PIPERACILLIN (15 patients)
LIPITOR (15 patients)
LEXOMIL (14 patients)
CLOPIDOGREL (14 patients)
OLANZAPINE (14 patients)
CABERGOLINE (14 patients)
TEMESTA (14 patients)
CLONAZEPAM (14 patients)
IBUPROFEN (14 patients)
NEURONTIN (13 patients)
LEVODOPA (13 patients)
WARFARIN SODIUM (13 patients)
SERENACE (13 patients)
OXYCONTIN (13 patients)
MEMANTINE HCL (13 patients)
ATENOLOL (13 patients)
DIOVAN (12 patients)
HIZENTRA (12 patients)
PRAMIPEXOLE DIHYDROCHLORIDE (12 patients)
ALBUTEROL (12 patients)
CELEBREX (12 patients)
HEPARIN (12 patients)
SEROQUEL XR (12 patients)
ENOXAPARIN SODIUM (12 patients)
ATORVASTATIN CALCIUM (12 patients)
ABILIFY (11 patients)
PLAVIX (11 patients)
FLUOXETINE (11 patients)
LOXAPINE HCL (11 patients)
COREG (11 patients)
TAXOTERE (11 patients)
GLEEVEC (11 patients)
VENLAFAXINE (11 patients)
PREVACID (11 patients)
CAPTOPRIL (11 patients)
CIPRO (11 patients)
CYCLOSPORINE (11 patients)
LANTUS (10 patients)
SYNTHROID (10 patients)
ACTONEL (10 patients)
MIRAPEX (10 patients)
KETOCONAZOLE (10 patients)
ANTIBIOTICS (10 patients)
ARICEPT (10 patients)
HEPARIN SODIUM INJECTION (10 patients)
AVONEX (10 patients)
RAMIPRIL (9 patients)
INSULIN (9 patients)
NECYRANE (9 patients)
MORPHINE (9 patients)
FERROUS SULFATE TAB (9 patients)
PRAZEPAM (9 patients)
DONEPEZIL HCL (9 patients)
CARBOCISTEINE (9 patients)
EXTAVIA (9 patients)
BROMOCRIPTINE MESYLATE (9 patients)
AMBIEN (9 patients)
AMOXICILLIN (9 patients)
RISPERDAL CONSTA (9 patients)
LAMICTAL (9 patients)
SINGULAIR (9 patients)
ECONAZOLE NITRATE (9 patients)
ARTANE (9 patients)
FOLIC ACID (9 patients)
PRAMIPEXOLE DIHYCHLLORIDE (9 patients)
LISINOPRIL (9 patients)
CEFUROXIME (9 patients)
LYSOPAINE (9 patients)
PRILOSEC (9 patients)
HYDROCHLOROTHIAZIDE (9 patients)
SANDIMMUNE (9 patients)
CYMBALTA (8 patients)
ELUDRIL (8 patients)
MIRTAZAPINE (8 patients)
SOLANAX (8 patients)
EPINEPHRINE (8 patients)
TYLENOL (CAPLET) (8 patients)
CIATYL Z (8 patients)
TRAMAL (8 patients)
AMIODARONE HCL (8 patients)
COUMADIN (8 patients)
NEUROCIL (8 patients)
OXAZEPAM (8 patients)
LEVEMIR (8 patients)
AVANDIA (8 patients)
NEXIUM (8 patients)
PROTONIX (8 patients)
ZOCOR (8 patients)
WELLBUTRIN (8 patients)
BIPERIDEN HYDROCHLORIDE TAB (8 patients)
METFORMIN HCL (7 patients)
NORVASC (7 patients)
METOPROLOL (7 patients)
TRIVASTAL (7 patients)
ZANAFLEX (7 patients)
HUMIRA (7 patients)
ALDACTONE (7 patients)
SOLU-CORTEF (7 patients)
ALLOPURINOL (7 patients)
TRIHEXYPHENIDYL HCL (7 patients)
PREVISCAN (7 patients)
DOPAMINE HCL (7 patients)
SERTRALINE HCL (7 patients)
THIOPENTAL SODIUM (7 patients)
ENALAPRIL MALEATE (7 patients)
BISOPROLOL FUMARATE (7 patients)
TRAZODONE HCL (7 patients)
LITHIUM CARBONATE (7 patients)
TYLENOL (7 patients)
TRANXENE (7 patients)
POTASSIUM CHLORIDE (7 patients)
CEFOTAXIME SODIUM (7 patients)
PREDONINE (7 patients)
ISOSORBIDE DINITRATE (7 patients)
CYTARABINE (7 patients)
VITAMIN D (7 patients)
CARBIDOPA AND LEVODOPA (6 patients)
LOVENOX (6 patients)
ACETYLSALICYLIC ACID SRT (6 patients)
ESCITALOPRAM (6 patients)
DEXAMETHASONE TAB (6 patients)
SERTRALINE HYDROCHLORIDE (6 patients)
EVEROLIMUS (6 patients)
TASMAR (6 patients)
ALPRAZOLAM (6 patients)
MANTADIX (6 patients)
PRAZINE (6 patients)
HERCEPTIN (6 patients)
DEROXAT (6 patients)
AMLODIPINE (6 patients)
METHYLPREDNISOLONE (6 patients)
PURSENNID (6 patients)
REMICADE (6 patients)
SILECE (6 patients)
ZOVIRAX (6 patients)
MYCOPHENOLATE MOFETIL (6 patients)
ARAVA (6 patients)
LEPTICUR (6 patients)
CARBAMAZEPINE (6 patients)
TOBRAMYCIN (6 patients)
SYMMETREL (6 patients)
ATIVAN (6 patients)
ATORVASTATIN (6 patients)
CIPRALEX (ESCITALOPRAM) (6 patients)
LYRICA (6 patients)
CLARITHROMYCIN (6 patients)
CITALOPRAM (6 patients)
VANCOMYCIN (6 patients)
HEPTAMINOL (6 patients)
AZILECT (6 patients)
HUMALOG (6 patients)
PREDNISONE TAB (6 patients)
PROPRANOLOL (6 patients)
PROCTOLOG (6 patients)
INTETRIX (6 patients)
RANITIDINE (6 patients)
MS CONTIN (5 patients)
Most common side effects for patients taking SOMALGIN:
DRUG INEFFECTIVE (30 patients)
BLOOD PRESSURE INCREASED (28 patients)
CEREBROVASCULAR ACCIDENT (27 patients)
MALAISE (19 patients)
INFARCTION (18 patients)
NERVOUSNESS (15 patients)
MYOCARDIAL INFARCTION (14 patients)
OEDEMA PERIPHERAL (14 patients)
DYSPNOEA (13 patients)
FEELING ABNORMAL (13 patients)
HYPERTENSION (13 patients)
VENOUS OCCLUSION (12 patients)
FALL (12 patients)
FATIGUE (12 patients)
VOMITING (12 patients)
BLOOD PRESSURE INADEQUATELY CONTROLLED (11 patients)
PNEUMONIA (11 patients)
HYPERGLYCAEMIA (11 patients)
PAIN IN EXTREMITY (10 patients)
CHEST PAIN (10 patients)
DEPRESSION (10 patients)
DIARRHOEA (10 patients)
DIZZINESS (10 patients)
SOMNOLENCE (10 patients)
PAIN (9 patients)
ARRHYTHMIA (9 patients)
COUGH (9 patients)
HEADACHE (9 patients)
ABASIA (8 patients)
CARDIAC ARREST (8 patients)
TACHYCARDIA (8 patients)
CORONARY ARTERY OCCLUSION (8 patients)
HYPERSENSITIVITY (8 patients)
NEPHROLITHIASIS (7 patients)
NASOPHARYNGITIS (7 patients)
ASTHENIA (7 patients)
CARDIAC FAILURE (7 patients)
PRURITUS (7 patients)
SUICIDAL IDEATION (7 patients)
VISION BLURRED (7 patients)
NAUSEA (7 patients)
INFLUENZA (7 patients)
HYPOAESTHESIA (7 patients)
ABDOMINAL PAIN (6 patients)
ANGINA PECTORIS (6 patients)
ANGIOPLASTY (6 patients)
ARTHRALGIA (6 patients)
PYREXIA (6 patients)
BLOOD PRESSURE DECREASED (6 patients)
CARDIAC DISORDER (6 patients)
INSOMNIA (6 patients)
CONFUSIONAL STATE (6 patients)
DEATH (6 patients)
ERYTHEMA (6 patients)
RESPIRATORY FAILURE (6 patients)
URTICARIA (6 patients)
HEART RATE DECREASED (6 patients)
HEART RATE IRREGULAR (6 patients)
ANXIETY (5 patients)
ARTERIAL OCCLUSIVE DISEASE (5 patients)
ARTHRITIS (5 patients)
BACK PAIN (5 patients)
BLINDNESS (5 patients)
BLOOD CHOLESTEROL INCREASED (5 patients)
BLOOD PRESSURE FLUCTUATION (5 patients)
INTENTIONAL DRUG MISUSE (5 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (5 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (5 patients)
OVERDOSE (5 patients)
DYSPHAGIA (5 patients)
STENT PLACEMENT (5 patients)
RENAL FAILURE (5 patients)
EYE DISORDER (5 patients)
MEMORY IMPAIRMENT (5 patients)
GAIT DISTURBANCE (5 patients)
WEIGHT INCREASED (5 patients)
WEIGHT DECREASED (5 patients)
GLAUCOMA (5 patients)
HYPOGLYCAEMIA (5 patients)
ISCHAEMIA (4 patients)
ACUTE RESPIRATORY FAILURE (4 patients)
SWELLING (4 patients)
TENSION (4 patients)
BLOOD GLUCOSE INCREASED (4 patients)
OSTEOPOROSIS (4 patients)
CARDIAC OPERATION (4 patients)
CARDIAC PACEMAKER INSERTION (4 patients)
VASCULAR GRAFT (4 patients)
CEREBRAL ISCHAEMIA (4 patients)
CONVULSION (4 patients)
DRUG PRESCRIBING ERROR (4 patients)
SWELLING FACE (4 patients)
LUNG DISORDER (4 patients)
EYE HAEMORRHAGE (4 patients)
FEELING OF DESPAIR (4 patients)
VISUAL IMPAIRMENT (4 patients)
MUSCULAR WEAKNESS (4 patients)
FRUSTRATION (4 patients)
GASTRITIS (4 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (4 patients)
NECK PAIN (4 patients)
HALLUCINATION (4 patients)
HEART RATE INCREASED (4 patients)
OFF LABEL USE (4 patients)
ABDOMINAL PAIN UPPER (3 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (3 patients)
ACUTE MYOCARDIAL INFARCTION (3 patients)
ALOPECIA (3 patients)
ANAEMIA (3 patients)
VISUAL ACUITY REDUCED (3 patients)
ANOREXIA (3 patients)
SURGERY (3 patients)
ASTHMA (3 patients)
ATRIAL FIBRILLATION (3 patients)
URINARY TRACT INFECTION (3 patients)
BLOOD CHOLESTEROL ABNORMAL (3 patients)
BLOOD PRESSURE ABNORMAL (3 patients)
PULMONARY OEDEMA (3 patients)
SEPSIS (3 patients)
BRONCHOPNEUMONIA (3 patients)
LYMPHOCYTE COUNT INCREASED (3 patients)
UNEVALUABLE EVENT (3 patients)
CARDIOVASCULAR DISORDER (3 patients)
CAROTID ARTERY OCCLUSION (3 patients)
CATARACT (3 patients)
CATARACT OPERATION (3 patients)
CHEST DISCOMFORT (3 patients)
WHITE BLOOD CELL COUNT INCREASED (3 patients)
COMA (3 patients)
CONDITION AGGRAVATED (3 patients)
CORONARY ARTERIAL STENT INSERTION (3 patients)
PETECHIAE (3 patients)
DEMENTIA ALZHEIMER'S TYPE (3 patients)
PROSTATE CANCER (3 patients)
DEPRESSED MOOD (3 patients)
DIABETES MELLITUS (3 patients)
PSYCHIATRIC SYMPTOM (3 patients)
DRUG DOSE OMISSION (3 patients)
IRRITABILITY (3 patients)
DRUG INTERACTION (3 patients)
DRUG INTOLERANCE (3 patients)
ISCHAEMIC STROKE (3 patients)
UPPER LIMB FRACTURE (3 patients)
SINUSITIS (3 patients)
SPEECH DISORDER (3 patients)
DYSPHONIA (3 patients)
INJECTION SITE PAIN (3 patients)
EMOTIONAL DISORDER (3 patients)
LAZINESS (3 patients)
TREMOR (3 patients)
LOSS OF CONSCIOUSNESS (3 patients)
JOINT SWELLING (3 patients)
MEDICATION RESIDUE (3 patients)
WOUND (3 patients)
WRONG DRUG ADMINISTERED (3 patients)
NEUTROPHIL COUNT INCREASED (3 patients)
HALLUCINATION, VISUAL (3 patients)
LUNG INFECTION (3 patients)
HEMIPLEGIA (3 patients)
HYPOTENSION (3 patients)
SINUS DISORDER (3 patients)
PLEURAL EFFUSION (2 patients)
ABDOMINAL DISTENSION (2 patients)
ABNORMAL FAECES (2 patients)
PROSTHESIS IMPLANTATION (2 patients)
AGITATION (2 patients)
PRODUCTIVE COUGH (2 patients)
APPLICATION SITE ERYTHEMA (2 patients)
APPLICATION SITE INFLAMMATION (2 patients)
APPLICATION SITE PRURITUS (2 patients)
MASTICATION DISORDER (2 patients)
AREFLEXIA (2 patients)
ARTERIOSCLEROSIS (2 patients)
BLOOD POTASSIUM DECREASED (2 patients)
BLOOD PRESSURE DIASTOLIC DECREASED (2 patients)
BLOOD TRIGLYCERIDES ABNORMAL (2 patients)
BLOOD URIC ACID INCREASED (2 patients)
BONE PAIN (2 patients)
PRODUCT ADHESION ISSUE (2 patients)
BREAST CANCER (2 patients)
BRONCHITIS (2 patients)
CHOLELITHIASIS (2 patients)
COLON CANCER (2 patients)
CONJUNCTIVITIS (2 patients)
CONSTIPATION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
CRYING (2 patients)
PAROSMIA (2 patients)
DECREASED APPETITE (2 patients)
PROTHROMBIN TIME ABNORMAL (2 patients)
POLYP (2 patients)
DEVICE OCCLUSION (2 patients)
PNEUMOTHORAX (2 patients)
DISORIENTATION (2 patients)
OSTEOPENIA (2 patients)
MUSCULOSKELETAL PAIN (2 patients)
MULTI-ORGAN FAILURE (2 patients)
GLUCOSE TOLERANCE IMPAIRED (2 patients)
HAEMATEMESIS (2 patients)
MUSCULOSKELETAL STIFFNESS (2 patients)
HIP ARTHROPLASTY (2 patients)
HUMERUS FRACTURE (2 patients)
HYPERHIDROSIS (2 patients)
HYPERSOMNIA (2 patients)
HYPERTHYROIDISM (2 patients)
PANCREATITIS (2 patients)
HYPOAESTHESIA ORAL (2 patients)
HYPOTHYROIDISM (2 patients)
OBSTRUCTION (2 patients)
INCORRECT DOSE ADMINISTERED (2 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for SOMALGIN


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about AKINESIA and SOMALGIN, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking SOMALGIN, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in SOMALGIN. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for SOMALGIN experts. If you are a healthcare provider experienced in prescribing SOMALGIN, please register here.

Your online appointment book for Macon Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use